This 2016 study evaluates the utility of liquid biopsies in monitoring metastatic melanoma progression. By analyzing circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) in blood samples, the research demonstrates that liquid biopsies can provide real-time insights into tumor dynamics, detect emerging resistance mutations, and assess treatment response. The
